Digital health’s latest IPO has liftoff

Sensors are the future of healthcare technology. So says former Apple CEO John Sculley—and tech giants are poised to change consumer health by adding remote monitoring capabilities to the likes of the Apple Watch and Google Nest. Elon Musk brainchild Neuralink wants to go one step further with its implantable brain-machine interface, starting in paralyzed patients. But with regulatory checkpoints and, well, actually having to decode the brain, we’re likely a long ways from such “symbiosis with AI.”

Digital health IPO watch update: last week, 14-year-old patient intake software maker Phreesia raised $167M in its public market debut, closing nearly 40% above its set price. We recently looked at what this year’s planned IPOs could signal about the near future.


Amazon May Take Surescripts To Court Over Data Holdout
PillPack’s business is predicated on access to prescription data CNBC | (Tweet)

CVS Kicks Off First Trial Of Its Home Dialysis Device
The goal is to facilitate longer, more frequent treatments FierceBiotech | (Tweet)

With CA Health System, Optum Creates New Collaboration Model
Taking over the backend enables providers to focus on patients MedCity News | (Tweet)

The Latest Monitoring Device Is In Your Baby’s Diaper
Now tracking can truly be from cradle to grave USA Today | (Tweet)

Philips Acquires Medumo To Help Hospitals Connect With Patients
The Dutch tech conglomerate is on a health acquisition streak CNBC | (Tweet)

Precision Medicine Is Crushing Once-Untreatable Cancers
But only a fraction of patients currently benefit Newsweek | (Tweet)

Google Glass’ Next Act: Teaching Autistic Children?
Researchers see promise in helping with emotion, eye contact The New York Times | (Tweet)

Recent Funding